Macquarie Group Ltd. lessened its position in Encompass Health Corp (AMEX:EHC) by 28.2% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 679,441 shares of the company’s stock after selling 266,856 shares during the period. Macquarie Group Ltd.’s holdings in Encompass Health were worth $46,012,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Hancock Holding Co. bought a new position in shares of Encompass Health in the 1st quarter valued at about $8,590,000. Smith Asset Management Group LP grew its position in shares of Encompass Health by 3.7% in the 2nd quarter. Smith Asset Management Group LP now owns 49,313 shares of the company’s stock valued at $3,339,000 after acquiring an additional 1,740 shares during the period. First Trust Advisors LP bought a new position in shares of Encompass Health in the 2nd quarter valued at about $5,693,000. Rothschild Asset Management Inc. lifted its stake in shares of Encompass Health by 41.3% during the 2nd quarter. Rothschild Asset Management Inc. now owns 290,885 shares of the company’s stock worth $19,699,000 after buying an additional 85,037 shares during the last quarter. Finally, Marietta Investment Partners LLC acquired a new stake in shares of Encompass Health during the 2nd quarter worth about $847,000. 93.18% of the stock is owned by institutional investors.

In other Encompass Health news, insider Cheryl B. Levy sold 28,955 shares of Encompass Health stock in a transaction dated Friday, August 3rd. The shares were sold at an average price of $78.00, for a total value of $2,258,490.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Andrew L. Price sold 9,457 shares of Encompass Health stock in a transaction dated Tuesday, August 14th. The stock was sold at an average price of $80.04, for a total transaction of $756,938.28. The disclosure for this sale can be found here. 1.60% of the stock is owned by insiders.

AMEX EHC opened at $57.67 on Friday. Encompass Health Corp has a 52-week low of $40.86 and a 52-week high of $59.29. The company has a debt-to-equity ratio of 1.89, a current ratio of 1.34 and a quick ratio of 1.34.

Encompass Health (AMEX:EHC) last issued its quarterly earnings data on Wednesday, July 25th. The company reported $0.99 earnings per share for the quarter, topping the consensus estimate of $0.83 by $0.16. Encompass Health had a net margin of 8.67% and a return on equity of 23.56%. The business had revenue of $1.07 billion during the quarter, compared to analysts’ expectations of $1.03 billion. The company’s revenue for the quarter was up 10.5% compared to the same quarter last year. research analysts forecast that Encompass Health Corp will post 2.72 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, October 15th. Shareholders of record on Monday, October 1st will be paid a $0.27 dividend. This is a boost from Encompass Health’s previous quarterly dividend of $0.25. The ex-dividend date of this dividend is Friday, September 28th. This represents a $1.08 annualized dividend and a yield of 1.87%.

A number of research firms have recently issued reports on EHC. Zacks Investment Research upgraded shares of Encompass Health from a “hold” rating to a “buy” rating and set a $84.00 target price for the company in a research note on Friday, July 27th. Mizuho restated a “buy” rating and set a $82.00 target price on shares of Encompass Health in a research note on Thursday, July 26th. Piper Jaffray Companies upgraded shares of Encompass Health from a “neutral” rating to an “overweight” rating in a research note on Thursday, July 26th. Credit Suisse Group raised their target price on shares of Encompass Health from $66.00 to $80.00 and gave the stock an “outperform” rating in a research note on Thursday, July 26th. Finally, SunTrust Banks restated a “buy” rating and set a $82.00 target price on shares of Encompass Health in a research note on Friday, July 20th. One analyst has rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. Encompass Health has a consensus rating of “Buy” and an average price target of $71.10.

About Encompass Health

Encompass Health Corporation, formerly HealthSouth Corporation, is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies.

Recommended Story: Stock Symbols and CUSIP Explained

Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Corp (AMEX:EHC).

Institutional Ownership by Quarter for Encompass Health (AMEX:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.